Assess how long your live microbe persists on representative surfaces to identify cross-contamination and facility onboarding risks. Our customizable evaluations generate data-driven cleaning recommendations and communication-ready risk summaries to strongly support your development-stage decision-making.
The development of Live Biotherapeutic Products (LBPs) introduces unique challenges. Because the active ingredient is a living organism, innovators often face scrutiny regarding the viability of their strains on inanimate surfaces. This presents practical concerns for cross-contamination in multi-product facilities and requires clear documentation to guide handling procedures.
Creative Biolabs delivers a modular, controlled risk evaluation service. We simulate exact manufacturing and clinical environments in vitro to assess the persistence kinetics of your therapeutic strain.
By coupling traditional culture-based recovery with complementary molecular techniques (like PMA-qPCR), we map the degradation curve of your microbe. This provides the half-life data and cleaning strategy validations necessary to build robust internal risk documentation and facilitate external discussions.
Our study designs are highly customizable, allowing us to align the experimental matrix with your specific intended use, manufacturing environment, and early-stage documentation needs.
| Evaluation Module | Test Parameters & Conditions | Analytical Output |
|---|---|---|
| Material Surface Library |
|
Substrate-specific recovery efficiency; Adhesion profiling. |
| Environmental Stressors |
|
Environmental impact mapping; Decimal reduction time (D-value). |
| Survival Kinetics (Time-Course) |
|
Estimated biological Half-Life (T1/2); Multi-phasic decay curves. |
| Cleaning Strategy Validation |
|
Log Reduction Value (LRV); Informative baseline for drafting cleaning SOPs. |
We go beyond simple binary "alive/dead" screens. By capturing high-resolution longitudinal data, we provide mathematical models of biological decay, giving you actionable D-values and T1/2 metrics for decision-support.
Integrating PMA-qPCR methodologies alongside standard CFU plating helps estimate membrane-intact cells. Since some stressed cells may remain non-culturable while still contributing to residual signals, this dual approach provides a more comprehensive understanding of persistence patterns.
Deliverables culminate in a tailored technical report detailing recovery rates, calculated kinetics, and external communication risk points. This documentation is highly useful for facility discussions, internal risk reviews, and development-stage planning.
While not a final regulatory batch-release assay, this evaluation provides critical early-stage intelligence for several pivotal milestones in a live biotherapeutic program.
Provide empirical data to prospective manufacturing partners demonstrating how your strain behaves and can be cleaned in shared environments.
Assess the specific persistence profile of a novel engineered or wild-type microbe before it enters a multi-product cleanroom.
Generate a baseline comparison of different biocidal agents to establish effective internal handling and decontamination protocols.
Build a robust data package during the development stage to address internal quality assurance reviews and early-stage risk mitigation planning.
Published research indicates that microbial survival on inanimate surfaces is highly strain-specific and strongly dependent on the interplay between the substrate material and ambient environmental conditions.
For instance, investigations by Hu et al. (2022) illustrate that different strains display dramatic variations in survival trajectories and mount diverse transcriptomic responses to environmental starvation and biocidal stress. These observed variations highlight that relying on generalized species-level assumptions can lead to incomplete risk evaluations.
For live microbial products, conducting specific surface persistence evaluations during the development stage helps project teams move beyond generalizations, identifying potential cleaning, handling, and facility onboarding risks early in the pipeline.
Fig.1 Surface survival of clinically relevant pathogens under different cleaning strategies and environmental conditions. 1,3
We execute highly structured, milestone-driven studies to ensure uncompromised data reliability and efficient turnaround times.
Define strain characteristics, matrix requirements, and target endpoints to guide the study design.
Drafting of a study protocol detailing specific coupons, sampling timelines, and analytical methodologies.
Controlled application of the live microbe onto substrates under monitored environmental conditions.
Standardized elution across timepoints, followed by CFU viability plating and optional molecular profiling.
Delivery of a technical report featuring survival curves and practical risk mitigation observations.
Navigating the persistence parameters of live biotherapeutics requires specialized infrastructure and deeply ingrained microbiological expertise.
Our assay frameworks are designed to provide fit-for-purpose data that aligns with industry expectations for assessing environmental persistence and preparing for multi-use facility changeovers.
By integrating classic plating with molecular techniques like qPCR or PMA-qPCR, we provide a broader picture of persistence, differentiating between actively growing cultures and residual genetic material or stressed cells.
Environmental persistence testing relies on immaculate control. Our laboratories utilize calibrated environmental chambers that precisely manipulate temperature, humidity, and UV exposure, securing reproducible datasets.
Our environmental persistence risk assessment is part of a holistic suite of live biotherapeutic analytics. To thoroughly characterize your strain's safety, efficacy, and viability profile, we highly recommend exploring the following integrated service offerings:
Yes. While traditional CFU plating evaluates cells capable of active replication under specific conditions, adding qPCR or PMA-qPCR provides a complementary perspective. Stressed cells on surfaces may sometimes lose culturability while retaining intact membranes. Offering dual readouts ensures you have a comprehensive understanding of both actively growing biomass and residual biological signals.
Absolutely. Our risk evaluation platform is highly modular. If your facility utilizes specialized materials (e.g., specific cleanroom epoxy grades, proprietary tubing) or relies on custom-formulated cleaning agents, you can provide these materials to us. We will incorporate them directly into the experimental protocol to ensure the data perfectly reflects your real-world handling scenarios.
We regularly handle strict anaerobes and oxygen-sensitive live biotherapeutics. Our facilities are equipped with specialized anaerobic workstations and controlled chambers. In fact, evaluating oxygen exposure is often a key parameter requested by clients to understand the natural decay rate of anaerobes when accidentally exposed to standard aerobic cleanroom environments.
The quantitative readouts from our studies—such as decay kinetics and chemical reduction baselines—form a robust foundation for your development-stage risk documentation. This objective data is highly useful for internal quality reviews, drafting effective standard operating procedures (SOPs), and facilitating productive, evidence-based discussions with CDMO partners regarding facility onboarding and cross-contamination mitigation.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.